Hjem › Brystkreft › Massachusetts › Quincy
Kliniske studier for Brystkreft i Quincy, MA
6 studier for Brystkreft søker deltakere på steder i og rundt Quincy (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Dana-Farber Brigham Cancer Center at South Shore Health, Weymouth · 4 mi unna
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) in Clinical Affiliation with South Shore Hospital, South Weymouth · 6 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Dana-Farber/Brigham and Women's Cancer Center at South Shore, South Weymouth · 6 mi unna
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruttererFase 2
- Dana Farber at South Shore Hospital, Weymouth · 4 mi unna
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekruttererFase 2
- DF/BWCC in Clinical Affiliation with South Shore Hospital, South Weymouth · 6 mi unna
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Rekrutterer
- Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital, Weymouth · 4 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Quincy
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.